{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"39.660","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"4,086,953,756","primaryexch":"HKEX","ric":"2269.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"B","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.8221,"inline_upper_strike_price":"","sedol":"BL6B9P1","am":"1.78","iv":"","ew_strike":"","as":"39.060","geographic_focus":null,"incorpin":"Cayman Islands","etp_baseCur":null,"ew_amt_os":"","bd":"39.040","registrar":"Tricor Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-26 10:38:37.0","lo52":"12.460","shares_issued_date":"8 Sep 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Ge Li","underlying_ric":"2269.HK","hi52":"40.600","issuer_name":"WuXi Biologics (Cayman) Inc.","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"38.060","mkt_cap":"159.63","f_aum_hkd":null,"ew_sub_per_to":"","ls":"39.060","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"-0.940","aum":"","issued_shares_class_B":null,"vo":"45.88","secondary_listing_flag":false,"listing_date":"13 Jun 2017","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"WuXi Biologics (Cayman) Inc.","nm_s":"WUXI BIO","sym":"2269","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.020","strike_price":"","summary":"WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.","op":"38.820","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"17/F<br/>Far East Finance Centre<br/>16 Harcourt Road<br/>Hong Kong","pc":"-2.35","days_to_expiry":null,"underlying_code":null,"pe":"44.87","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"40.000","isin":"KYG970081173","moneyness":""}},"qid":"1758889963425"}
